Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. The company was founded by Alan H. Auerbach on September 15, 2010 and is headquartered in Los Angeles, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
172
Frequently Asked Questions
What is Market Cap of Puma Biotechnology Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Puma Biotechnology Inc market cap is $228.68M.
What is the 52-week high for Puma Biotechnology Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Puma Biotechnology Inc 52 week high is $6.07 as of September 12, 2025.
What is the 52-week low for Puma Biotechnology Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Puma Biotechnology Inc 52 week low is $2.32 as of September 12, 2025.
What is Puma Biotechnology Inc stock price today?
Puma Biotechnology Inc stock price today is $4.50.
What was Puma Biotechnology Inc stock price yesterday?
Puma Biotechnology Inc stock price yesterday was $4.54.
What is the PE ratio of Puma Biotechnology Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Puma Biotechnology Inc’s P/E ratio is 4.63.
What is the Price-to-Book ratio of Puma Biotechnology Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Puma Biotechnology Inc P/B ratio is 2.1631.
What is the 50-day moving average of Puma Biotechnology Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Puma Biotechnology Inc 50-day moving average is $4.12.
How many employess does Puma Biotechnology Inc has?